Martingale Asset Management L P raised its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 32.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,901 shares of the medical instruments supplier’s stock after acquiring an additional 2,700 shares during the quarter. Martingale Asset Management L P owned approximately 0.29% of Utah Medical Products worth $790,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Rice Hall James & Associates LLC raised its holdings in Utah Medical Products by 1.1% during the second quarter. Rice Hall James & Associates LLC now owns 3,829 shares of the medical instruments supplier’s stock valued at $277,000 after acquiring an additional 40 shares during the period. Strs Ohio raised its holdings in Utah Medical Products by 8.0% during the second quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock valued at $195,000 after acquiring an additional 200 shares during the period. Seizert Capital Partners LLC raised its holdings in Utah Medical Products by 5.2% during the second quarter. Seizert Capital Partners LLC now owns 6,512 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 320 shares during the period. Janney Montgomery Scott LLC raised its holdings in Utah Medical Products by 9.3% during the second quarter. Janney Montgomery Scott LLC now owns 3,947 shares of the medical instruments supplier’s stock valued at $286,000 after acquiring an additional 335 shares during the period. Finally, WCM Investment Management CA raised its holdings in Utah Medical Products by 0.9% during the second quarter. WCM Investment Management CA now owns 81,912 shares of the medical instruments supplier’s stock valued at $5,930,000 after acquiring an additional 695 shares during the period. 66.77% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have recently weighed in on UTMD. BidaskClub lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. ValuEngine upgraded Utah Medical Products from a “sell” rating to a “hold” rating in a research report on Tuesday, June 6th.

Utah Medical Products, Inc. (NASDAQ:UTMD) opened at 73.70 on Monday. Utah Medical Products, Inc. has a 12 month low of $56.30 and a 12 month high of $75.00. The stock’s 50 day moving average price is $71.84 and its 200-day moving average price is $67.45. The stock has a market cap of $274.09 million, a price-to-earnings ratio of 21.14 and a beta of 0.74.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be given a $0.265 dividend. The ex-dividend date is Thursday, September 14th. This represents a $1.06 dividend on an annualized basis and a dividend yield of 1.44%. Utah Medical Products’s dividend payout ratio (DPR) is currently 30.37%.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/utah-medical-products-inc-utmd-holdings-raised-by-martingale-asset-management-l-p/1586419.html.

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.